- About us
- A new Institute dedicated to combating leukemia
- Medical-scientific program
- History of Hematology on the Saint-Louis Campus
- The Leukemia Institute’s governance
- Press
- Contact us
- Our news
- Profile of Valéria Bisio, Research Officer
- Creation of a Hemato-Oncogenetics Unit
- Profile of Alice Gros, a peer-support patient
- Winners of the Leukemia Institute’s first call for projects
- Profile of Julien Calvo, researcher
- Support us
- Join us
- You are
- Patients and relatives
- To be cared for and supported
- Become an expert patient
- Discover the Leukemia Institute
- Researchers
- Research
- Clinical trials
- Discover the Leukemia Institute
- Healthcare professionals
- Refer a patient
- Our clinical research
- Discover the Leukemia Institute
- Industry partners
- Discover the Leukemia Institute
- Translational research
- Donors
- Support us
- Discover the Leukemia Institute
- Care
- Patient care
- Being Treated at the Leukemia Institute
- Cancer treatments
- Supportive Care
- Open Multidisciplinary Meetings
- Our clinical services
- Saint-Louis Hospital – Department of adult hematology
- Saint-Louis Hospital – Hematology Transplant Unit
- Saint-Louis Hospital – Department of Pharmacology and Clinical Investigations
- Saint-Louis Hospital – Adolescent and Young Adult Unit
- Saint-Louis Hospital – Outpatient Hemato-oncogenetics Unit
- Saint-Louis Hospital – Department of senior hematology
- Robert-Debré Hospital – Department of pediatric hematology and immunology
- Necker Hospital – Department of Adult Hematology
- Cochin–Port Royal Hospital – Department of clinical hematology
- Avicenne Hospital – Department of clinical hematology and cell therapy
- Our medical laboratories
- Hematology Medical Laboratory, Michaela Fontenay
- Hematology Medical Laboratory, Jean Soulier
- Molecular Genetics Unit, Hélène Cavé
- Hematology Medical Laboratory, Vahid Asnafi
- Patient information
- Acute Myeloid Leukemias
- Acute Lymphoblastic Leukemias
- Myeloproliferative Neoplasms
- Myelodysplastic Syndrome
- Cancer treatments
- Supportive Care
- Psychological Support
- Research
- Our research teams
- Hugues de Thé’s team – Molecular pathology
- Raphaël Itzykson’s team – Functional precision medicine for leukemia
- Michaela Fontenay’s team – Normal and pathological hematopoiesis
- Françoise Pflumio’s team – Niche, Cancer, and Radiation in Hematopoiesis
- Sylvie Méléard’s team – Population Evolution and Interaction Particle Systems
- David Michonneau’s team – Translational Immunology in Immunotherapy and Hematology (TIGITH)
- Lina Benajiba’s team – Identification and targeting of extrinsic regulators of myeloid malignancies
- Karl Balabanian’s team – Lymphoid niches, Chemokines and Immuno-hematological syndromes
- Alexandre Puissant’s team – Molecular Mechanisms of Acute Myeloid Leukemia Development
- Stéphane Giraudier’s team – Chronic Myeloid Malignancies, Microenvironment & Translational Research
- Diana Passaro’s team – Leukemia & Niche Dynamics
- Camille Lobry’s team – Genetic and Epigenetic control of Normal and Malignant Hematopoiesis
- Jean Soulier’s team – Stem cell dysfunction and secondary AML
- Sylvie Chevret’s team – Biostatistics and clinical epidemiology
- Our technological platforms
- Our clinical research
Accueil Jean Soulier’s team – Stem cell dysfunction and secondary AMLJean Soulier’s team – Stem cell dysfunction and secondary AML
...Jean Soulier
Team leader
Institut de recherche Saint-Louis
Research themes
Clonal evolution in bone marrow failure syndrome as Fanconi anemia can result into ‘adaptive’ somatic genetic rescue, rescuing the HSC defect, or into ‘maladaptive’ evolution towards acute myeloid leukemia.
We profile patient samples at the single cell level and model bone marrow evolution using in vitro and mice experimental systems.
The adaptive or maladaptive deregulated pathways involve DNA damage response, inflammation, stem cell homeostasis and myeloid oncogenes.
Data inform on the BM dysfunction and pathway to sAML, with insights for patients staging and follow up.
- Bone marrow failure
- Fanconi anemia
- Aplastic anemia
- Leukemia
- Secondary AML
- MDS
- Genomic instability
Research areas
AML and MDS predisposition
Somatic genetic rescue in bone marrow failure
Featured research projects
Pathogenesis of secondary leukemias
Marie de Tersant
Adaptive somatic genetic rescue in Fanconi anemia
Lise Larcher
Jean Soulier's team members
Jean SOULIERPU-PH, UPC and APHPLise LARCHERPharD, doctorante Inserm FRMMarie DE TERSANTMD, doctorante PA InsermChristophe ANTONIEWSKIDR2, CNRS – GenomicsClaude GAZINCRCN, CNRSLoïc MAILLARDPhD, IR, CNRSLucie HERNANDEZAI, UPCVesnie ETIENNEIE, UPC – AnimalsNadia VASQUEZPhD, IG APHP, CRMR AplasieMélanie DA COSTAIG APHP, CRMR AplasieScientific publications
Berrada et al, Nucleic Acids Res., 2023
A clickable melphalan for monitoring DNA interstrand crosslink accumulation and detecting ICL repair defects in Fanconi anemia patient cellsRead the publicationSébert et al, Cell Stem Cell, 2023
Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemiaRead the publicationStay up to date by subscribing to the institute's newsletter
- Discover the Leukemia Institute
- Translational research
- Our clinical research
- Clinical trials
- Become an expert patient
- To be cared for and supported
- A new Institute dedicated to combating leukemia